Financial Burden Assessment in Patients With Stage I-III Colon or Rectal Cancer Undergoing Treatment
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Abramson Cancer Center at Penn Medicine
Mayo Clinic
Milton S. Hershey Medical Center
Pierre Fabre Medicament
Freenome Holdings Inc.
CHA University
University of Utah
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Academic and Community Cancer Research United
Institut Bergonié
VA Office of Research and Development
Grupo Espanol de Tumores Neuroendocrinos
Konkuk University Medical Center
Boston Scientific Corporation
Indiana University
Karaganda Medical University
Ottawa Hospital Research Institute
Austrian Breast & Colorectal Cancer Study Group
Imperial College London
Pfizer
HKGepitherapeutics
Pfizer
Chinese University of Hong Kong
University of New Mexico
Mike O'Callaghan Military Hospital
Henry Ford Health System
Karolinska Institutet
Pfizer
Merit Medical Systems, Inc.
Massachusetts General Hospital
GlaxoSmithKline
SWOG Cancer Research Network
Amgen
Massachusetts General Hospital
Organon and Co
National Institutes of Health Clinical Center (CC)
University of California, San Diego
Exact Sciences Corporation
Karolinska Institutet
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
University of Chicago
Universitätsklinikum Hamburg-Eppendorf
Spanish Breast Cancer Research Group
Institute for Clinical and Experimental Medicine
Northwestern University
Hoffmann-La Roche
Rigshospitalet, Denmark
GlaxoSmithKline
GlaxoSmithKline